Advanced Rheumatology of Houston has the honor to participate in worldwide research studies for a select number of rheumatologic conditions. The mission of these research studies is to test an investigational new drug that will improve the lives of patients. Conditions like lupus and rheumatoid arthritis are manageable through medication.
However, some patients do not respond to the commonly used medications for these illnesses. Research studies set out to test new drugs, so patients have more opportunities for a comfortable life. Patients with rheumatologic conditions have an opportunity to participate in testing these new drugs.
Each research study has its own criteria participants must meet. Additionally, research studies often include free medication, clinic visits, and travel stipends. It is studies like these where patients feel like they are helping others. If you are interested, then you can view the requirements on each studies’ respective page.
Advanced Rheumatology of Houston is currently participating in three research studies: SLE-BRAVE, The contRAst Program, and KEEPsAKE.
Patients with lupus may have a chance to participate in the SLE-BRAVE research study. Lupus currently has no cure, and many medications available do not work for everyone. Lupus can be fatal, and this research study aims to bring a new drug to the market. The study will last approximately 62 weeks or 14 months. Participants will have a chance to take part in a longer study afterward. Visit the lupus research study page for more details.
The contRAst Program is splintered into three different studies and will test a new drug for rheumatoid arthritis (RA). RA is the most common type of autoimmune arthritis. The disease affects millions of Americans, which is why The contRAst Program is so important. If the new investigational drug is successful, then it will slow down the progression of rheumatoid arthritis. Participants must be at least 18 years old and meet other criteria. Visit The contRAst Program page to find additional details on the rheumatoid arthritis research study.
Similarly to The contRAst Program, the KEEPsAKE study is divided into two different studies: KEEPsAKE 1 and KEEPsAKE 2. The KEEPsAKE research study is testing a new investigational drug for psoriatic arthritis. Participants will only be split up into two groups for 24 weeks. One group will get the real medication while the other will be given a placebo. After 24 weeks, every participant will be given the actual drug. Interested patients should visit the KEEPsAKE page to see if they qualify for the psoriatic arthritis research study.
Research studies are extensive as they last for months or even years. Most importantly, they help those who do not respond to current medications. If you are interested in any of the aforementioned research studies, then get in touch with Advanced Rheumatology of Houston today. Patients can reach the clinic by calling (281) 766-7886. Be sure to visit the research study pages to find additional information and qualifying criteria.